Innovative hepatitis C therapies
Several new drugs treating the hepatitis C virus were approved by the FDA this year, with more on the way by the end of 2014 and into the beginning of 2015. This revolutionary new class of oral, direct-acting antiviral drugs is showing a much higher success rate in patients. The projected outcomes of these new […]
READ MOREAffordable Care Act provides greater accessibility for colorectal cancer screening
According to the American Cancer Society, colorectal cancer is the second leading cause of cancer deaths in men and women combined. However, the risk of death could be cut in half if the majority of people aged 50 and older would participate in recommended routine screenings. So why are people not getting screened? One of […]
READ MOREDecember 1-7 is #IBDAwarenessWeek!
From the Crohn’s and Colitis Foundation of America’s website: On November 14, 2011, the U.S. Senate passed Senate Resolution 199 (SR 199): “A resolution supporting the goals and ideals of Crohn’s and Colitis Awareness Week, December 1-7.” S. Res. 199 expresses appreciation to the family members and caregivers who support people in the United States […]
READ MORE